TNI Bureau: In order to strengthen the fight against coronavirus, the Government of India has inked a deal with domestic vaccine maker Biological-E for 30 crore Covid-19 vaccine doses.
Union Ministry of Health has finalised arrangements with Hyderabad based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses. These vaccine doses will be manufactured and stockpiled by M/s Biological-E from August-December 2021.
For this purpose, the Union Ministry of Health would be making an advance payment of Rs. 1500 crore to M/s Biological-E.
Support Independent Journalism? Keep us live.
The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trial.
The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months.
Biological-E COVID Vaccine candidate has been supported by Government of India from Preclinical stage to Phase-3 studies. Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 cr but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad.
Comments are closed.